Abstract
Purpose
The aim of this Intensive Care Medicine Rapid Practice Guideline (ICM‑RPG) was to formulate evidence‑based guidance for the use of dexmedetomidine for sedation in invasively mechanically ventilated adults in the intensive care unit (ICU).
Methods
We adhered to the methodology for trustworthy clinical practice guidelines, including use of the Grading of Recommendations Assessment, Development, and Evaluation approach to assess the certainty of evidence, and the Evidence-to-Decision framework to generate recommendations. The guideline panel comprised 28 international panelists, including content experts, ICU clinicians, methodologists, and patient representatives. Through teleconferences and web‑based discussions, the panel provided input on the balance and magnitude of the desirable and undesirable effects, the certainty of evidence, patients’ values and preferences, costs and resources, feasibility, acceptability, and research priorities.
Results
The ICM‑RPG panel issued one weak recommendation (suggestion) based on overall moderate certainty of evidence: "In invasively mechanically ventilated adult ICU patients, we suggest using dexmedetomidine over other sedative agents, if the desirable effects including a reduction in delirium are valued over the undesirable effects including an increase in hypotension and bradycardia".
Conclusion
This ICM-RPG provides updated evidence-based guidance on the use of dexmedetomidine for sedation in mechanically ventilated adults, and outlines uncertainties and research priorities.
References
Reade MC, Finfer S (2014) Sedation and delirium in the intensive care unit. N Engl J Med 370:444–454. https://doi.org/10.1056/NEJMra1208705
Zaal IJ, Devlin JW, Peelen LM, Slooter AJC (2015) A systematic review of risk factors for delirium in the ICU*. Crit Care Med 43:40–47. https://doi.org/10.1097/CCM.0000000000000625
Devlin JW, Skrobik Y, Gélinas C et al (2018) Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 46:e825–e873. https://doi.org/10.1097/CCM.0000000000003299
Duprey MS, Dijkstra-Kersten SMA, Zaal IJ et al (2021) Opioid use increases the risk of delirium in critically Ill adults independently of pain. Am J Respir Crit Care Med 204:566–572. https://doi.org/10.1164/rccm.202010-3794OC
Weerink MAS, Struys MMRF, Hannivoort LN et al (2017) Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet 56:893–913. https://doi.org/10.1007/s40262-017-0507-7
Chue PS, Chue JA (2017) A review of the clinical uses of dexmedetomidine. Int J Clin Anesthesiol 5:1080
Jakob SM (2012) Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation. JAMA 307:1151. https://doi.org/10.1001/jama.2012.304
Erickson SJ, Millar J, Anderson BJ et al (2020) Dexmedetomidine sedation in mechanically ventilated critically ill children: a pilot randomized controlled trial. Pediatr Crit Care Med 21:e731–e739. https://doi.org/10.1097/PCC.0000000000002483
Riker RR (2009) Dexmedetomidine vs midazolam for sedation of critically Ill patients. A Randomized Trial JAMA 301:489. https://doi.org/10.1001/jama.2009.56
Shehabi Y, Howe BD, Bellomo R et al (2019) Early sedation with dexmedetomidine in critically Ill patients. N Engl J Med 380:2506–2517. https://doi.org/10.1056/NEJMoa1904710
Hughes CG, Mailloux PT, Devlin JW et al (2021) Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis. N Engl J Med 384:1424–1436. https://doi.org/10.1056/nejmoa2024922
Lewis K et al (2022) Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials. Intensive Care Med. https://doi.org/10.1007/s00134-022-06712-2
Alhazzani W, Møller MH, Belley-Cote E, Citerio G (2019) Intensive care medicine rapid practice guidelines (ICM-RPG): paving the road of the future. Intensive Care Med 45:1639–1641. https://doi.org/10.1007/s00134-019-05786-9
Laake JH, Astvad M, Bentsen G et al (2022) A policy for diversity, equity, inclusion and anti-racism in the scandinavian society of anaesthesiology and intensive care medicine (SSAI). Acta Anaesthesiol Scand 66:141–144. https://doi.org/10.1111/aas.13978
Weiss B, Weiss B, Prisco L et al (2019) Statement paper on diversity for the European society of intensive care medicine (ESICM). Intensive Care Med 45:1002–1005. https://doi.org/10.1007/s00134-019-05606-0
Schünemann HJ, Wiercioch W, Brozek J et al (2017) GRADE evidence to decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol 81:101–110. https://doi.org/10.1016/j.jclinepi.2016.09.009
Alhazzani W, Lewis K, Jaeschke R et al (2018) Conflicts of interest disclosure forms and management in critical care clinical practice guidelines. Intensive Care Med 44:1691–1698
Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64:395–400. https://doi.org/10.1016/j.jclinepi.2010.09.012
Wetterslev J, Thorlund K, Brok J, Gluud C (2008) Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61:64–75. https://doi.org/10.1016/j.jclinepi.2007.03.013
Hultcrantz M, Rind D, Akl EA et al (2017) The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol 87:4–13. https://doi.org/10.1016/j.jclinepi.2017.05.006
Santesso N, Glenton C, Dahm P et al (2020) GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol 119:126–135. https://doi.org/10.1016/j.jclinepi.2019.10.014
Turunen H, Jakob SM, Ruokonen E et al (2015) Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation. Crit Care 19:67. https://doi.org/10.1186/s13054-015-0787-y
CADTH (2017) Dexmedetomidine for sedation in the critical care setting: an economic assessment. CADTH Technol Rev 6:1–79
Shehabi Y, Serpa Neto A, Howe BD et al (2021) Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial. Intensive Care Med 47:455–466. https://doi.org/10.1007/s00134-021-06356-8
Donroe JH, Tetrault JM (2017) Substance use, intoxication, and withdrawal in the critical care setting. Crit Care Clin 33:543–558. https://doi.org/10.1016/j.ccc.2017.03.003
Shelton KT, Qu J, Bilotta F et al (2018) Minimizing ICU neurological dysfunction with dexmedetomidine-induced sleep (MINDDS): protocol for a randomised, double-blind, parallel-arm, placebo-controlled trial. BMJ Open 8:e020316. https://doi.org/10.1136/bmjopen-2017-020316
Acknowledgements
We are very grateful to the patient representatives Olaf Schroeder and Maria Høpner for being members of the guideline panel.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interests
All co-authors declared their conflicts of interests (Supplementary Material).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Møller, M.H., Alhazzani, W., Lewis, K. et al. Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline. Intensive Care Med 48, 801–810 (2022). https://doi.org/10.1007/s00134-022-06660-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-022-06660-x